Stoke Therapeutics, Inc. is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen ...

Life changes can be fantastic, but they can sometimes be shockingly challenging. Whether you’re contemplating a career switch, dealing with tricky relationship dynamics, or facing financial upheaval, ...

In late January 2026, Axsome Therapeutics reported interim unaudited fourth-quarter 2025 results pointing to about US$196,000,000 in product revenue and roughly US$638,500,000 for full-year 2025, with ...

Eli Lilly and Company (NYSE:LLY) reported fourth-quarter financial results on Wednesday. The transcript from the earnings call has been provided below.

Discover 7 proven strategies for CRM and ERP integration for supply chain optimization—backed by real ROI data, architecture insights, and implementation roadmaps to boost efficiency by 40%+.